Canaccord Genuity Maintains Buy on DocGo, Lowers Price Target to $5
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity analyst Richard Close maintains a Buy rating on DocGo (NASDAQ:DCGO) but lowers the price target from $9 to $5.

May 09, 2024 | 6:47 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Canaccord Genuity maintains a Buy rating on DocGo but lowers the price target from $9 to $5.
The reduction in price target by Canaccord Genuity suggests a reassessment of DocGo's future financial performance or market position, potentially due to underlying challenges or revised expectations. This could lead to short-term negative sentiment among investors, impacting the stock's price negatively.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100